Retatrutide 40mg

Description

Retatrutide 40mg – High Purity Triple Agonist Research Peptide (LY3437943)

Discover the cutting-edge of metabolic research with Retatrutide 40mg, a potent synthetic peptide and first-in-class triple hormone receptor agonist. Also known as LY3437943, this advanced research compound targets GLP-1, GIP, and glucagon receptors simultaneously, making it one of the most studied peptides for appetite regulation, energy expenditure, and body weight management in laboratory settings.

Key Features & Benefits for Research:

• Triple Agonist Power: Retatrutide activates three key receptors (GIP/GLP-1/glucagon) in a single molecule, offering researchers a unique tool to explore synergistic effects on metabolism, satiety, and glucose control — often referred to as the “triple G” or next-generation peptide in obesity and diabetes studies.
• High Concentration Vial: The 40mg format provides maximum research flexibility for extended protocols, dose-response studies, or multi-cycle experiments. Ideal for labs requiring higher volumes without frequent reconstitution.
• Premium Quality: ≥99% purity (HPLC/MS verified), lyophilized white powder for stability. Each vial is sealed and lab-tested for consistency and accuracy.
• Research Potential: Early clinical data on retatrutide has shown substantial reductions in body weight (up to ~24% in phase 2 studies at higher doses over 48 weeks), improved cardiometabolic markers, and effects on gastric emptying and energy balance. Perfect for in vitro, in vivo, or preclinical metabolic research.

Common Research Applications:

• Weight loss and obesity models
• Type 2 diabetes and glycemic control studies
• Appetite suppression and feeding behavior research
• Fatty liver disease and lipid metabolism investigations
• Comparative studies vs. dual agonists (e.g., tirzepatide/semaglutide)

Product Specifications:

• Peptide Name: Retatrutide (LY3437943)
• Amount: 40mg per vial
• Form: Lyophilized powder (reconstitute with bacteriostatic water)
• Sequence: Synthetic 39-amino acid peptide with modifications for enhanced stability
• Intended Use: Strictly for laboratory research and scientific investigation only. Not for human consumption, diagnostic, or therapeutic use.

Important Notice: Retatrutide is an investigational compound still undergoing clinical trials and is not FDA-approved for any medical use. All sales are for research purposes only. Always follow proper lab safety protocols, reconstitution guidelines, and local regulations when handling research peptides.

Elevate your metabolic research with Retatrutide 40mg — the powerful triple agonist peptide trusted by researchers exploring next-level weight management and endocrine pathways.

Buy Retatrutide 40mg online today for fast shipping and verified high-purity peptides. Bulk discounts and COAs available upon request.